FDA — authorised 6 October 1959
- Application: NDA012071
- Marketing authorisation holder: MERCK
- Local brand name: DECADRON
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Decadron in United States
FDA authorised Decadron on 6 October 1959
Marketing authorisations
FDA — authorised 7 July 1960
- Application: NDA012376
- Marketing authorisation holder: MERCK
- Local brand name: DECADRON
- Indication: ELIXIR — ORAL
- Status: approved
FDA — authorised 20 June 1962
- Application: NDA013422
- Marketing authorisation holder: HARROW EYE
- Local brand name: MAXIDEX
- Indication: SUSPENSION/DROPS — OPHTHALMIC
- Status: approved
FDA — authorised 23 October 1973
- Application: ANDA083342
- Marketing authorisation holder: ALCON
- Local brand name: MAXIDEX
- Indication: OINTMENT — OPHTHALMIC
- Status: approved
FDA
- Status: approved
Decadron in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Decadron approved in United States?
Yes. FDA authorised it on 6 October 1959; FDA authorised it on 7 July 1960; FDA authorised it on 20 June 1962.
Who is the marketing authorisation holder for Decadron in United States?
MERCK holds the US marketing authorisation.